Biotechnology - Pharmaceutical, Dermatologicals

Filter

Popular Filters

AAD conference briefs: Celgene's apremilast; and Sanofi's dupilumab

04-03-2013

The European subsidiary of US biotech firm Celgene Corp (Nasdaq: CELG) presented the results from ESTEEM…

apremilastBiotechnologyCelgeneDermatologicalsdupilumabPharmaceuticalRegeneronResearchSanofi

LEO Pharma and 4SC Discovery link for skin disease research

26-02-2013

Privately-held Danish dermatology specialist LEO Pharma has entered into an exclusive research and license…

4SC DiscoveryBiotechnologyDermatologicalsLEO PharmaLicensingPharmaceuticalResearch

Genentech Ph III study of omalizumab shows promise in CIU

25-02-2013

Genentech, the US biotech subsidiary of Swiss drug major Roche (ROG: SIX), announced results from a Phase…

BiotechnologyDermatologicalsGenentechNovartisOmalizumabPharmaceuticalRegulationResearchRespiratory and PulmonaryRocheXolair

LEO Pharma in over $300 million deal for psoriasis therapy

10-01-2012

Privately-held Danish drugmaker LEO Pharma A/S has signed a multi-million dollar in-licensing deal with…

BiotechnologyDermatologicalsLEO PharmaLicensingPharmaceuticalVirobay

Back to top